1. [1] Chang DS, Hsu E, Hottinger DG, Cohen SP. Anti-nerve growth factor in pain management: current evidence. J Pain Res 2016; 9: 373. [DOI:10.2147/JPR.S89061] [PMID] [PMCID]

2. [2] Azhary H, Farooq MU, Bhanushali M, Majid A, Kassab MY. Peripheral neuropathy: differential diagnosis and management. Am Fam Phys 2010; 81: 887-892.

3. [3] Uddin SJ, Hasan M, Afroz M, Sarker DK, Rouf R, Islam MT, et al. Curcumin and its multi-target function against pain and inflammation: an update of pre-clinical data. Curr Drug Target 2021; 22: 656-671. [DOI:10.2174/1389450121666200925150022] [PMID]

4. [4] Ji RR, Suter MR. p38 MAPK, microglial signaling, and neuropathic pain. Mol Pain 2007; 3: 10.1186/1744-8069-3-33. [DOI:10.1186/1744-8069-3-33] [PMID] [PMCID]

5. [5] Costigan M, Scholz J, Woolf CJ. Neuropathic pain: a maladaptive response of the nervous system to damage. Ann Rev Neurosci 2009; 32: 1-32. [DOI:10.1146/annurev.neuro.051508.135531] [PMID] [PMCID]

6. [6] Chattopadhyay I, Biswas K, Bandyopadhyay U, Banerjee RK. Turmeric and curcumin: Biological actions and medicinal applications. CURRENT SCIENCE-BANGALORE- 2004; 87: 44-53.

7. [7] Aggarwal BB, Kumar A, Bharti AC. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 2003; 23: 363-398.

8. [8] Wang TY, Chen JX. Effects of curcumin on vessel formation insight into the pro-and antiangiogenesis of curcumin. Evid Based Complement Alternat Med 2019; 2019: 1390795. [DOI:10.1155/2019/1390795] [PMID] [PMCID]

9. [9] Chen M, Du ZY, Zheng X, Li DL, Zhou RP, Zhang K. Use of curcumin in diagnosis, prevention, and treatment of Alzheimer's disease. Neural Regen Res 2018; 13: 742. [DOI:10.4103/1673-5374.230303] [PMID] [PMCID]

10. [10] Fusar-Poli L, Vozza L, Gabbiadini A, Vanella A, Concas I, Tinacci S, et al. Curcumin for depression: a meta-analysis. Crit Rev Food Sci Nutr 2020; 60: 2643-2653. [DOI:10.1080/10408398.2019.1653260] [PMID]

11. [11] Daugherty DJ, Marquez A, Calcutt NA, Schubert D. A novel curcumin derivative for the treatment of diabetic neuropathy. Neuropharmacology 2018; 129: 26-35. [DOI:10.1016/j.neuropharm.2017.11.007] [PMID] [PMCID]

12. [12] Perrone L, Squillaro T, Napolitano F, Terracciano C, Sampaolo S, Melone MA. The autophagy signaling pathway: a potential multifunctional therapeutic target of curcumin in neurological and neuromuscular diseases. Nutrients 2019; 11: 1881. [DOI:10.3390/nu11081881] [PMID] [PMCID]

13. [13] Vina J, Sanchis‐Gomar F, Martinez‐Bello V, Gomez‐Cabrera M. Exercise acts as a drug; the pharmacological benefits of exercise. Br J Pharmacol 2012; 167: 1-12. [DOI:10.1111/j.1476-5381.2012.01970.x] [PMID] [PMCID]

14. [14] Hutchinson KJ, Gómez‐Pinilla F, Crowe MJ, Ying Z, Basso DM. Three exercise paradigms differentially improve sensory recovery after spinal cord contusion in rats. Brain 2004; 127: 1403-1414. [DOI:10.1093/brain/awh160] [PMID]

15. [15] Cotman CW, Berchtold NC, Christie LA. Exercise builds brain health: key roles of growth factor cascades and inflammation. Trends Neurosci 2007; 30: 464-472. [DOI:10.1016/j.tins.2007.06.011] [PMID]

16. [16] Hayes K, Sprague S, Guo M, Davis W, Friedman A, Kumar A, et al. Forced, not voluntary, exercise effectively induces neuroprotection in stroke. Acta Neuropathol 2008; 115: 289-296. [DOI:10.1007/s00401-008-0340-z] [PMID] [PMCID]

17. [17] Davranche K, McMorris T. Specific effects of acute moderate exercise on cognitive control. Brain Cogn 2009; 69: 565-570. [DOI:10.1016/j.bandc.2008.12.001] [PMID]

18. [18] Greenwood BN, Fleshner M. Exercise, learned helplessness, and the stress-resistant brain. Neuromol Med 2008; 10: 81-98. [DOI:10.1007/s12017-008-8029-y] [PMID]

19. [19] Koltyn KF, Brellenthin AG, Cook DB, Sehgal N, Hillard C. Mechanisms of exercise-induced hypoalgesia. J Pain 2014; 15: 1294-1304. https://doi.org/10.1016/j.jpain.2014.09.006 [DOI:10.1016/j.jpain.2014.01.412] [PMID] [PMCID]

20. [20] Smith BE, Hendrick P, Bateman M, Holden S, Littlewood C, Smith TO, Logan P. Musculoskeletal pain and exercise-challenging existing paradigms and introducing new. Br J Sport Med 2019; 53: 907-912. [DOI:10.1136/bjsports-2017-098983] [PMID] [PMCID]

21. [21] Dannecker EA, Koltyn KF. Pain during and within hours after exercise in healthy adults. Sport Med 2014; 44: 921-942. [DOI:10.1007/s40279-014-0172-z] [PMID]

22. [22] Sarkaki A, Saadipour K, Badavi M, Alaei H, Rahim F. Effects of forced treadmill exercise on pain threshold in morphine-addicted rats. J Clin Diagn Res 2007; 1: 555-560.

23. [23] Bennett GJ, Xie YK. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 1988; 33: 87-107. [DOI:10.1016/0304-3959(88)90209-6]

24. [24] Jarahi M, Sheibani V, Safakhah H, Torkmandi H, Rashidy-Pour A. Effects of progesterone on neuropathic pain responses in an experimental animal model for peripheral neuropathy in the rat: a behavioral and electrophysiological study. Neuroscience 2014; 256: 403-411. [DOI:10.1016/j.neuroscience.2013.10.043] [PMID]

25. [25] Stagg NJ, Mata HP, Ibrahim MM, Henriksen EJ, Porreca F, Vanderah TW, Philip Malan T. Regular exercise reverses sensory hypersensitivity in a rat neuropathic pain model: role of endogenous opioids. J Am Soc Anesth 2011; 114: 940-948. [DOI:10.1097/ALN.0b013e318210f880] [PMID] [PMCID]

26. [26] Pajardi G, Bortot P, Ponti V, Novelli C. Clinical usefulness of oral supplementation with alpha-lipoic acid, curcumin phytosome, and B-group vitamins in patients with carpal tunnel syndrome undergoing surgical treatment. Evid Based Complement Alternat Med 2014; 2014: 891310. [DOI:10.1155/2014/891310] [PMID] [PMCID]

27. [27] Zhang L, Ding X, Wu Z, Wang M, Tian M. Curcumin alleviates pain and improves cognitive impairment in a rat model of cobra venom-induced trigeminal neuralgia. J Pain Res 2018; 11: 1095. [DOI:10.2147/JPR.S162668] [PMID] [PMCID]

28. [28] Kasmaie FM, Jahromi Z, Gazor R, Zaminy A. Comparison of melatonin and curcumin effect at the light and dark periods on regeneration of sciatic nerve crush injury in rats. EXCLI J 2019; 18: 653.

29. [29] Zhang X, Guan Z, Wang X, Sun D, Wang D, Li Y, et al. Curcumin alleviates oxaliplatin-induced peripheral neuropathic pain through inhibiting oxidative stress-mediated activation of NF-κB and mitigating inflammation. Biol Pharm Bull 2020; 43: 348-355. [DOI:10.1248/bpb.b19-00862] [PMID]

30. [30] Liu S, Li Q, Zhang MT, Mao-Ying QL, Hu LY, Wu GC, et al. Curcumin ameliorates neuropathic pain by down-regulating spinal IL-1β via suppressing astroglial NALP1 inflammasome and JAK2-STAT3 signalling. Sci Rep 2016; 6: 1-14. [DOI:10.1038/srep28956] [PMID] [PMCID]

31. [31] Liu GM, Xu K, Li J, Luo YG. Curcumin upregulates S100 expression and improves regeneration of the sciatic nerve following its complete amputation in mice. Neural Regen Res 2016; 11: 1304. [DOI:10.4103/1673-5374.189196] [PMID] [PMCID]

32. [32] Babu A, Prasanth K, Balaji B. Effect of curcumin in mice model of vincristine-induced neuropathy. Pharm Biol 2015; 53: 838-848. [DOI:10.3109/13880209.2014.943247] [PMID]

33. [33] Lee JH, Kim YD, Jung HC, Cheong YK. The effect of intrathecal curcumin on mechanical allodynia in rats after L5 spinal nerve ligation. Korean J Anesthesiol 2014; 67: S122. [DOI:10.4097/kjae.2014.67.S.S122] [PMID] [PMCID]

34. [34] Li Y, Zhang Y, Liu D-b, Liu HY, Hou WG, Dong YS. Curcumin attenuates diabetic neuropathic pain by downregulating TNF-α in a rat model. Int J Med Sci 2013; 10: 377. [DOI:10.7150/ijms.5224] [PMID] [PMCID]

35. [35] Jia T, Rao J, Zou L, Zhao S, Yi Z, Wu B, et al. Nanoparticle-encapsulated curcumin inhibits diabetic neuropathic pain involving the P2Y12 receptor in the dorsal root ganglia. Front Neurosci 2018; 11: 755. [DOI:10.3389/fnins.2017.00755] [PMID] [PMCID]

36. [36] Safakhah HA, Kor NM, Bazargani A, Bandegi AR, Pourbadie HG, Khoshkholgh-Sima B, Ghanbari A. Forced exercise attenuates neuropathic pain in chronic constriction injury of male rat: an investigation of oxidative stress and inflammation. J Pain Res 2017; 10: 1457. [DOI:10.2147/JPR.S135081] [PMID] [PMCID]

37. [37] Cobianchi S, Casals-Diaz L, Jaramillo J, Navarro X. Differential effects of activity dependent treatments on axonal regeneration and neuropathic pain after peripheral nerve injury. Exp Neurol 2013; 240: 157-167. [DOI:10.1016/j.expneurol.2012.11.023] [PMID]

38. [38] Dobson JL, McMillan J, Li L. Benefits of exercise intervention in reducing neuropathic pain. Front Cell Neurosci 2014; 8: 102. [DOI:10.3389/fncel.2014.00102] [PMID] [PMCID]

39. [39] Guo JB, Chen BL, Wang Y, Zhu Y, Song G, Yang Z, et al. Meta-analysis of the effect of exercise on neuropathic pain induced by peripheral nerve injury in rat models. Front Neurol 2019; 10: 636. [DOI:10.3389/fneur.2019.00636] [PMID] [PMCID]

40. [40] Chen YW, Li YT, Chen YC, Li ZY, Hung CH. Exercise training attenuates neuropathic pain and cytokine expression after chronic constriction injury of rat sciatic nerve. Anesth Analg 2012; 114: 1330-1337. [DOI:10.1213/ANE.0b013e31824c4ed4] [PMID]

41. [41] Ghanbari A, Asgari A, Kaka G, Falahatpishe H, Naderi A, Jorjani M. In vivo microdialysis of glutamate in ventroposterolateral nucleus of thalamus following electrolytic lesion of spinothalamic tract in rats. Exp Brain Res 2014; 232: 415-421. [DOI:10.1007/s00221-013-3749-0] [PMID]

42. [42] Detloff MR, Smith EJ, Molina DQ, Ganzer PD, Houlé JD. Acute exercise prevents the development of neuropathic pain and the sprouting of non-peptidergic (GDNF-and artemin-responsive) c-fibers after spinal cord injury. Exp Neurol 2014; 255: 38-48. [DOI:10.1016/j.expneurol.2014.02.013] [PMID] [PMCID]

43. [43] Sumizono M, Sakakima H, Otsuka S, Terashi T, Nakanishi K, Ueda K, et al. The effect of exercise frequency on neuropathic pain and pain-related cellular reactions in the spinal cord and midbrain in a rat sciatic nerve injury model. J Pain Res 2018; 11: 281. [DOI:10.2147/JPR.S156326] [PMID] [PMCID]

44. [44] Jarrahi M, Rashidy-Pour A, Safakhah HA. Preventive effects of progesterone against neuropathic pain responses in a rat model of chronic constriction injury. Koomesh 2019; 21: 164-170. (Persian).